Intramuscular Interferon- -1a: A Viewpoint by Steven L. Galetta

ISSN： 1172-7047

Source： CNS Drugs, Vol.19, Iss.1, 2005-01, pp. : 63-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended-Release Intramuscular Naltrexone: A Viewpoint by Steven Siegel

By Siegel Steven

Drugs, Vol. 66, Iss. 13, 2006-01 ,pp. : 1752-1754

Adis International

Access to resources Recommend Favorite

Interferon--1a: First report of intramuscular abscess: 4 case reports

Reactions Weekly, Vol. 1, Iss. 1051, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Ranibizumab: A Viewpoint by Steven D. Schwartz

By Schwartz Steven D.

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1207-1209

Adis International

Access to resources Recommend Favorite

Intramuscular Interferon- -1a: In Patients at High Risk of Developing Clinically Definite Multiple Sclerosis

By M. Asif A. Siddiqui Keri Wellington

CNS Drugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 55-61

Adis International

Access to resources Recommend Favorite

Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a: Modelling the Clinical and Economic Implications

By Guo Shien Bozkaya Duygu

PharmacoEconomics, Vol. 27, Iss. 1, 2009-01 ,pp. : 39-53

Adis International

Access to resources Recommend Favorite